#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14458	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2291	754.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1448	1448	C	923	C,T	922,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24590	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4230	726.0	0	.	n	.	0	T695C	SNP	695	695	T	1342	1342	C	863	C,G,A	861,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24590	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4230	726.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1984	1984	A	954	A	954	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24590	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4230	726.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2618	2618	C	876	C,T	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24590	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4230	726.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2692	2692	A	798	A,C	796,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24590	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4230	726.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3244	3244	C	832	C,A	831,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1986	folP	855	855	100.0	folP.l15.c4.ctg.1	2169	114.2	1	SNP	p	R229S	0	.	.	685	687	CGC	1350	1352	CGC	195;195;199	C;G;C	195;195;199	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5112	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3933	162.3	1	SNP	p	S91F	0	.	.	271	273	TCC	826	828	TCC	169;173;174	T;C;C	169;173;174	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5112	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3933	162.3	1	SNP	p	D95G	0	.	.	283	285	GAC	838	840	GAC	177;180;180	G;A;C	177;180;180	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5112	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3933	162.3	1	SNP	p	D95N	0	.	.	283	285	GAC	838	840	GAC	177;180;180	G;A;C	177;180;180	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1864	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1873	124.3	1	SNP	p	G45D	1	.	.	133	135	GAC	738	740	GAC	223;222;222	G;A,C;C	223;221,1;222	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1042	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1478	87.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4746	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3523	168.0	1	SNP	p	D86N	0	.	.	256	258	GAC	905	907	GAC	212;211;210	G;A;C,T	212;211;209,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4746	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3523	168.0	1	SNP	p	S88P	0	.	.	262	264	TCC	911	913	TCC	212;210;214	T;C,G;C	212;209,1;214	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4034	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3163	159.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1809	1811	GGC	213;209;208	G,A;G,C;C	212,1;208,1;208	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1622	1624	GCA	216;215;217	G,T;C;A	215,1;215;217	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1625	1627	ATC	215;214;212	A;T,A;C,A	215;213,1;211,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1637	1639	GTG	216;219;220	G,T;T;G	215,1;219;220	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1637	1639	GTG	216;219;220	G,T;T;G	215,1;219;220	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2141	2143	ACC	228;229;229	A,G;C;C,G	227,1;229;228,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2195	2197	GCG	225;225;223	G,A;C;G	224,1;225;223	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2195	2197	GCG	225;225;223	G,A;C;G	224,1;225;223	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2318	2320	GGC	214;215;213	G;G;C	214;215;213	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2327	2329	GGC	221;221;220	G,C;G,A;C	219,2;220,1;220	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3107	156.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2345	2347	CTG	225;225;225	C;T,C;G,T,C	225;224,1;223,1,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5476	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3502	194.9	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1801	1803	CCG	203;202;201	C;C;G	203;202;201	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2234	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2457	113.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	778	780	GGC	163;161;163	G;G;C	163;161;163	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2234	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2457	113.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	960	960	C	168	C,G	167,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	368	porB1a	984	165	92.12	porB1a.l15.c30.ctg.2	165	65.9	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	68	70	GAT	87;87;87	G;A;T	87;87;87	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	368	porB1a	984	165	92.12	porB1a.l15.c30.ctg.2	165	65.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	71	73	AGT	87;87;87	A;G;T	87;87;87	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	368	porB1a	984	165	92.12	porB1a.l15.c30.ctg.2	165	65.9	0	.	p	.	0	D276N	NONSYN	826	828	GAT	77	79	AAC	87;87;87	A;A;C	87;87;87	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	368	porB1a	984	165	92.12	porB1a.l15.c30.ctg.2	165	65.9	0	.	p	.	0	N277H	NONSYN	829	831	AAC	80	82	CAC	87;87;87	C;A;C	87;87;87	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	683	685	GAA	294;299;301	G;A,C;A,G	294;298,1;300,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	K120D	NONSYN	358	360	AAG	929	931	GAC	263;262;262	G;A;C	263;262;262	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	989	991	AAA	279;283;284	A,G;A,G;A	277,1;281,1;283	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	998	1000	GAA	277;274;275	G,A;A;A	275,1;273;274	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1130	1132	CGA	255;254;256	C,A;G;A	254,1;254;256	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	S189G	NONSYN	565	567	AGC	1136	1138	GGC	258;260;257	G,A;G;C,T	257,1;260;255,2	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1205	1207	GAT	286;284;283	G;A;T	286;284;283	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	D213N	NONSYN	637	639	GAT	1208	1210	AAT	284;285;286	A;A;T	284;285;286	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	T215S	NONSYN	643	645	ACT	1214	1216	TCT	285;284;287	T;C,T;T	285;283,1;287	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	G255Q	NONSYN	763	765	GGA	1334	1336	CAA	220;216;213	C;A;A	220;216;213	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	.	INDELS	766	768	ACA	1338	1342	ATCAA	213;210;210;207;207	A,C;T;C;A;A	212,1;210;210;207;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	.	INDELS	769	770	TG	1345	1347	AGT	205;208;206	A;G;T	205;208;206	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	A259D	NONSYN	775	777	GCT	1352	1354	GAT	204;203;200	G,A;A;T	203,1;203;200	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1412	1414	GTA	229;234;236	G;T;A	229;234;236	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1457	1459	GAT	237;241;244	G;A;T	237;241;244	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1466	1468	AAC	249;249;250	A;A;C	249;249;250	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3170	porB1b	1047	1047	96.87	porB1b.l15.c17.ctg.1	1768	219.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1469	1471	CAC	250;250;248	C;A;C	250;250;248	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10232	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5382	237.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1642	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1650	124.4	1	SNP	p	V57M	1	.	.	169	171	ATG	849	851	ATG	295;292;288	A;T;G	295;292;288	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
